Bruce D Gelb1. 1. Departments of Pediatrics and Human Genetics, Mount Sinai School of Medicine, New York, New York 10029, USA. bruce.gelb@mssm.edu
Abstract
PURPOSE OF REVIEW: Although the care of infants and children with congenital heart defects has been revolutionized over the past 50 years, their underlying causes have been obscure. Recent progress, accelerated through the Human Genome Project, has resulted in the rapid identification of disease genes causing congenital heart defects. RECENT FINDINGS: In this review, progress in identifying new congenital heart defect genes for specific lesions and in understanding their disease pathogenesis in the past year are detailed. Specifically, genes relevant for atrial and atrioventricular septal defects, patent ductus arteriosus, bicuspid aortic valve, and coarctation of the aorta as well as pulmonary valvar and branch stenosis are reviewed. SUMMARY: The information in this review provides insights into the state-of-the-art knowledge about the molecular genetic causes of congenital heart defects. It suggests that DNA testing may become standard for many forms of congenital heart defects, improving clinicians' ability to anticipate complications for their patients and predict recurrence risk for families of children with congenital heart defects.
PURPOSE OF REVIEW: Although the care of infants and children with congenital heart defects has been revolutionized over the past 50 years, their underlying causes have been obscure. Recent progress, accelerated through the Human Genome Project, has resulted in the rapid identification of disease genes causing congenital heart defects. RECENT FINDINGS: In this review, progress in identifying new congenital heart defect genes for specific lesions and in understanding their disease pathogenesis in the past year are detailed. Specifically, genes relevant for atrial and atrioventricular septal defects, patent ductus arteriosus, bicuspid aortic valve, and coarctation of the aorta as well as pulmonary valvar and branch stenosis are reviewed. SUMMARY: The information in this review provides insights into the state-of-the-art knowledge about the molecular genetic causes of congenital heart defects. It suggests that DNA testing may become standard for many forms of congenital heart defects, improving clinicians' ability to anticipate complications for their patients and predict recurrence risk for families of children with congenital heart defects.
Authors: Luca Carta; Lygia Pereira; Emilio Arteaga-Solis; Sui Y Lee-Arteaga; Brett Lenart; Barry Starcher; Christian A Merkel; Marina Sukoyan; Alexander Kerkis; Noriko Hazeki; Douglas R Keene; Lynn Y Sakai; Francesco Ramirez Journal: J Biol Chem Date: 2005-12-28 Impact factor: 5.157
Authors: Priti M Patel; Allison M Momany; Kendra L Schaa; Paul A Romitti; Charlotte Druschel; Margaret E Cooper; Mary L Marazita; Jeffrey C Murray; John M Dagle Journal: J Pediatr Date: 2016-06-22 Impact factor: 4.406
Authors: Melinda Csáky-Szunyogh; Attila Vereczkey; Zsolt Kósa; Balázs Gerencsér; Andrew E Czeizel Journal: Pediatr Cardiol Date: 2013-07-11 Impact factor: 1.655
Authors: Ina E Amarillo; Shawn O'Connor; Caroline K Lee; Marcia Willing; Jennifer A Wambach Journal: Am J Med Genet A Date: 2015-08-19 Impact factor: 2.802